Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Kansas City, KA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Kansas City, KA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Baton Rouge, LA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Covington, LA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Covington, LA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
New Orleans, LA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Annapolis, MD
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Annapolis, MD
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis
mi
from
Baltimore, MD
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis
mi
from
Baltimore, MD
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative site
mi
from
Boston, MA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative site
mi
from
Boston, MA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative site
mi
from
Boston, MA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Worcester, MA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Worcester, MA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Detroit, MI
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Detroit, MI
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Detroit, MI
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigator Site
mi
from
Minneapolis, MN
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Jackson, MS
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Jackson, MS
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Picayune, MS
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Picayune, MS
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Kansas City, MO
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Saint Louis, MO
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Saint Louis, MO
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Omaha, NE
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Brooklyn, NY
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Brooklyn, NY
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Kingston, NY
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Kingston, NY
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
New Hyde Park, NY
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Rochester, NY
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Stony Brook, NY
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Chapel Hill, NC
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Durham, NC
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Raleigh, NC
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigator Site
mi
from
Canton, OH
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigator Site
mi
from
Canton, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Cincinnati, OH
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Cincinnati, OH
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Cleveland, OH
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Columbus, OH
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Columbus, OH
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Toledo, OH
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Toledo, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis
mi
from
Portland, OR
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Abington, PA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Abington, PA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Natrona Heights, PA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Natrona Heights, PA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Philadelphia, PA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Philadelphia, PA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Philadelphia, PA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Wynnewood, PA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative site
mi
from
Providence, RI
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative site
mi
from
Providence, RI
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Warwick, RI
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Warwick, RI
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Greenville, SC
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Greenville, SC
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Greenville, SC
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Greenville, SC
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Nashville, TN
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Nashville, TN
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Nashville, TN
Click here to add this to my saved trials